Mary McElroy has worked in lung discovery and safety assessment for over 25 years. At Charles River, Mary combines her current role as Head of the Discovery Pharmacology and Toxicology with previous roles as an inhalation toxicologist and academic group leader in respiratory biology. Mary received her PhD from the University of Southampton and performed her postdoctoral work at the University of California at San Francisco. She has an MSc in Toxicology, an MBA from the Open University, and is a European Registered Toxicologist.